UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063578
Receipt number R000072678
Scientific Title Research on Neuromodulation and Psychological Modulation Techniques for Improving Sports Performance
Date of disclosure of the study information 2026/11/10
Last modified on 2026/11/10 11:31:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on Neuromodulation and Psychological Modulation Techniques for Improving Sports Performance

Acronym

Research on Neuromodulation and Psychological Modulation Techniques for Improving Sports Performance

Scientific Title

Research on Neuromodulation and Psychological Modulation Techniques for Improving Sports Performance

Scientific Title:Acronym

Research on Neuromodulation and Psychological Modulation Techniques for Improving Sports Performance

Region

Japan


Condition

Condition

Adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

While numerous methods for physical conditioning have been proposed to help athletes achieve peak performance, the methods for modulating brain function remain unclear. Furthermore, in recent years, techniques such as non invasive direct electrical stimulation of the brain have been proposed as methods for modulating human brain function. However, it is not yet clear how these techniques affect athletic performance. This study aims to improve athletes performance by regulating brain function. Specifically, it seeks to understand the mechanisms underlying brain function regulation through electrophysiological and psychological methods and to clarify the effects of these methods on performance.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Perform a motor learning task (reaching task) and evaluate it based on the learning rate.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

taVNS stimulation is performed using the taVNS stimulator (Soterix Medical) or the neuroStym tES stimulator (Neuro Device). Stimulation parameters are based on the protocol by Badran et al., with the stimulation intensity set at twice the sensory threshold (or an intensity of 5 mA or less) (Badran et al., 2018).

Interventions/Control_2

Sham stimulation is performed using the taVNS stimulator (Soterix Medical) or the neuroStym tES stimulator (Neuro Device).

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

The study will include healthy men and women (including athletes) aged 18 to 60. Participants must confirm that they have no objections to having their physiological parameters measured.

Key exclusion criteria

Under the conditions for administering noninvasive stimulation, the following individuals shall be excluded:
The following subjects shall be excluded: those with metal or metal plates in the neck or higher; those with a pacemaker or implantable pump; those with a history of craniotomy; those with cardiovascular or pulmonary disorders; those with autonomic nervous system disorders; those with musculoskeletal injuries or significant sequelae that would interfere with the study; those with skin lesions at the stimulation site; and those with a history of epilepsy.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Rieko
Middle name
Last name Osu

Organization

Waseda university

Division name

Faculty of Human Sciences

Zip code

3591165

Address

Room 205, Frontier Research Center (Building 110), School of Human Sciences, Waseda University, 135-1 Horinouchi, Tokorozawa City, Saitama Prefecture

TEL

0429476848

Email

r.osu@waseda.jp


Public contact

Name of contact person

1st name Riku
Middle name
Last name Nakazato

Organization

Waseda university

Division name

Faculty of Human Sciences

Zip code

3591165

Address

110-205, Waseda University, 135-1 Horinouchi, Tokorozawa City, Saitama Prefecture

TEL

08057517805

Homepage URL


Email

physeter.newt@gmail.com


Sponsor or person

Institute

Waseda University

Institute

Department

Personal name



Funding Source

Organization

NTT Communication Science Laboratories

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Waseda University Office of Research Ethics

Address

1-104 Totsuka-cho, Shinjuku-ku, Tokyo 169-8050

Tel

0352721639

Email

rinri@list.waseda.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

早稲田大学(埼玉県)


Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 11 Month 01 Day

Date of IRB


Anticipated trial start date

2026 Year 11 Month 02 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 11 Month 10 Day

Last modified on

2026 Year 11 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072678